Lyme disease is a recently recognized inflammatory disease characterized by distinctive skin lesions and involvement of the joints, nervous system, and heart (13) . Epidemiological studies early on linked the disease with the bite of the ixodid tick, Ixodes dammini, and convincing evidence now has been provided that a spirochete harbored by this tick is the etiological agent of Lyme disease (3, 12) . Although a great deal has been learned about the cause, clinical manifestations, and therapy of Lyme disease, relatively little is known about the host and bacterial factors involved in its pathogenesis. In this study we evaluated the interaction between peripheral blood phagocytes and the Lyme disease spirochete, and our findings suggest that these cells may play a role in host defense against this microorganism.
The Lyme disease spirochete used for these studies, kindly provided by A. C. Steere, Yale University, New Haven, Conn., was isolated from cerebrospinal fluid of a patient and was stored at -70°C. A 0.5-ml sample of thawed spirochetes was inoculated into 7 ml of modified Kelly medium (2) and cultivated in 30°C for 6 days. Radiolabeled spirochetes were obtained by cultivation in the presence of 0.1 nmol of [3H]thymidine (specific activity, 90 Ci/mmol; New England Nuclear Corp., Boston, Mass.). Human polymorphonuclear leukocytes (PMNs) and monocytes were obtained from venous blood of healthy donors by previously described techniques (6, 10) .
For the purposes of this study, we modified a recently described assay system (8) similar in design to the "surface phagocytosis" methodologies first described by Wood et al. (14) that permit investigation of opsonin-independent (nonspecific) and opsonin-mediated phagocytosis. PMNs or monocytes (2.5 x 106 cells in 0. (Fig. 1B) in a manner paralleling the results of the phagocytosis experiments (see above and Fig. 1A) .
Since the oxygen metabolites responsible for PMN CL participate in the process of microbial killing (4, 11), we investigated whether phagocytized spirochetes were also killed. A modification of a fluorochrome microassay (8, 9) was used to assess intracellular survival. Onto acid-washed glass cover slips, 250 p.l of a bacterial suspension (5 x 106 spirochetes) was added, and the cover slips were incubated for 2 h at 37°C. After gentle rinsing, 200-,ul suspensions of phagocytic cells (105 cells in GHBSS) were added to each cover slip and incubated at 37°C for 30 min. The nonadherent cells were then decanted, and acridine orange (1:10,000 in 0.87% NaCl) was added for 30 s. In this assay, live organisms appear green and dead organisms appear red when examined with a UV fluorescence microscope (9) . After 30 min of incubation, we determined that more than 50% of the cell-associated bacteria were dead (red). Similar results were obtained with PMNs and monocytes from three normal donors and with spirochetes opsonized with immune rabbit serum. Non-cell-associated spirochetes and control spirochetes (opsonized and unopsonized) that had been incubated similarly but in the absence of phagocytes uniformly appeared green. PMNs were also obtained from a patient with chronic granulomatous disease, a disease associated with a defect in the generation of reactive oxygen species (5), and these cells also killed more than 50% of the cell-associated spirochetes. These findings indicate that PMNs and monocytes are capable of killing intracellular spirochetes and that although phagocytosis is associated with stimulation of oxidative metabolism, oxygen-independent mechanisms of killing may also participate in the spirocheticidal activity of these cells. It should be pointed out, however, that the isolate used in these studies was determined to be catalase 1 ,um. negative, raising the possibility that the oxidative metabolism of the spirochete itself may contribute to its intracellular demise. Further studies therefore will be necessary to define the susceptibility of the Lyme disease spirochete to oxygen metabolites as well as to phagocyte-derived oxygen-independent microbicidal products.
